140 related articles for article (PubMed ID: 36153853)
1. Roles of Follicle-Stimulating Hormone on Bone Metabolism in Late Postmenopausal Women.
Jeong C; Kim J; Lim Y; Ha J; Kim MK; Kwon HS; Song KH; Kang MI; Baek KH
J Bone Metab; 2022 Aug; 29(3):175-183. PubMed ID: 36153853
[TBL] [Abstract][Full Text] [Related]
2. Association of follicle-stimulating hormone with bone turnover markers and bone mineral density in Chinese women across the menopausal transition.
Li L; Pi YZ; Zhang H; Dai RC; Yuan LQ; Sheng ZF; Wu XY
J Clin Lab Anal; 2023 May; 37(9-10):e24899. PubMed ID: 37272770
[TBL] [Abstract][Full Text] [Related]
3. Follicle-stimulating hormone is associated with low bone mass in postmenopausal women.
Mattick LJ; Bea JW; Hovey KM; Wactawski-Wende J; Cauley JA; Crandall CJ; Tian L; Ochs-Balcom HM
Osteoporos Int; 2023 Apr; 34(4):693-701. PubMed ID: 36692543
[TBL] [Abstract][Full Text] [Related]
4. FSH may mediate the association between HbA1c and bone turnover markers in postmenopausal women with type 2 diabetes.
Zha KX; An ZM; Ge SH; Cai J; Zhou Y; Ying R; Zhou J; Gu T; Guo H; Zhao Y; Wang NJ; Lu YL
J Bone Miner Metab; 2022 May; 40(3):468-477. PubMed ID: 35059887
[TBL] [Abstract][Full Text] [Related]
5. Follicle-stimulating hormone and bioavailable estradiol are less important than weight and race in determining bone density in younger postmenopausal women.
Gourlay ML; Preisser JS; Hammett-Stabler CA; Renner JB; Rubin J
Osteoporos Int; 2011 Oct; 22(10):2699-708. PubMed ID: 21125395
[TBL] [Abstract][Full Text] [Related]
6. Follicle-stimulating hormone is independently associated with lean mass but not BMD in younger postmenopausal women.
Gourlay ML; Specker BL; Li C; Hammett-Stabler CA; Renner JB; Rubin JE
Bone; 2012 Jan; 50(1):311-6. PubMed ID: 22086136
[TBL] [Abstract][Full Text] [Related]
7. Follicle-stimulating hormone and blood lead levels with bone mineral density and the risk of fractures in pre- and postmenopausal women.
Tong H; Su B; Liu Z; Chen Y
Front Endocrinol (Lausanne); 2022; 13():1054048. PubMed ID: 36605937
[TBL] [Abstract][Full Text] [Related]
8. Serum FSH Is Associated With BMD, Bone Marrow Adiposity, and Body Composition in the AGES-Reykjavik Study of Older Adults.
Veldhuis-Vlug AG; Woods GN; Sigurdsson S; Ewing SK; Le PT; Hue TF; Vittinghoff E; Xu K; Gudnason V; Sigurdsson G; Kado DM; Eiriksdottir G; Harris T; Schafer AL; Li X; Zaidi M; Rosen CJ; Schwartz AV
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1156-e1169. PubMed ID: 33326040
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density and bone turnover in relation to serum leptin, alpha-ketoglutarate and sex steroids in overweight and obese postmenopausal women.
Filip R; Raszewski G
Clin Endocrinol (Oxf); 2009 Feb; 70(2):214-20. PubMed ID: 18547340
[TBL] [Abstract][Full Text] [Related]
10. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density.
Rannevik G; Jeppsson S; Johnell O; Bjerre B; Laurell-Borulf Y; Svanberg L
Maturitas; 1995 Feb; 21(2):103-13. PubMed ID: 7752947
[TBL] [Abstract][Full Text] [Related]
11. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
12. Bone turnover alterations across the menopausal transition in south-eastern Chinese women [corrected].
Ma L; Song Y; Li C; Wang E; Zheng D; Qu F; Zhou J
Climacteric; 2016 Aug; 19(4):400-5. PubMed ID: 27147201
[TBL] [Abstract][Full Text] [Related]
13. Role of serum FSH measurement on bone resorption in postmenopausal women.
García-Martín A; Reyes-García R; García-Castro JM; Rozas-Moreno P; Escobar-Jiménez F; Muñoz-Torres M
Endocrine; 2012 Apr; 41(2):302-8. PubMed ID: 21964645
[TBL] [Abstract][Full Text] [Related]
14. The impact of serum FSH and estradiol on postmenopausal osteoporosis related to time since menopause.
Yoldemir T; Erenus M; Durmusoglu F
Gynecol Endocrinol; 2012 Nov; 28(11):884-8. PubMed ID: 22731753
[TBL] [Abstract][Full Text] [Related]
15. Effect of anastrozole on hormone levels in postmenopausal women with early breast cancer.
Kyvernitakis I; Albert US; Kalder M; Winarno AS; Hars O; Hadji P
Climacteric; 2015 Feb; 18(1):63-8. PubMed ID: 24884402
[TBL] [Abstract][Full Text] [Related]
16. Cadmium, follicle-stimulating hormone, and effects on bone in women age 42-60 years, NHANES III.
Gallagher CM; Moonga BS; Kovach JS
Environ Res; 2010 Jan; 110(1):105-11. PubMed ID: 19875111
[TBL] [Abstract][Full Text] [Related]
17. Bone turnover markers and bone density across the menopausal transition.
Ebeling PR; Atley LM; Guthrie JR; Burger HG; Dennerstein L; Hopper JL; Wark JD
J Clin Endocrinol Metab; 1996 Sep; 81(9):3366-71. PubMed ID: 8784098
[TBL] [Abstract][Full Text] [Related]
18. [Relationship of iron overload to bone mass density and bone turnover in postmenopausal women with fragility fractures of the hip].
Zhang LL; Jiang XF; Ai HZ; Jin ZD; Xu JX; Wang B; Xu W; Xie ZG; Zhou HB; Dong QR; Xu YJ
Zhonghua Wai Ke Za Zhi; 2013 Jun; 51(6):518-21. PubMed ID: 24091266
[TBL] [Abstract][Full Text] [Related]
19. [Number of teeth and hormonal profile of postmenopausal women with osteoporosis, osteopenia and normal bone mineral density--a preliminary study].
Stagraczyński M; Kulczyk T; Leszczyński P; Męczekalski B
Pol Merkur Lekarski; 2015 Oct; 39(232):214-8. PubMed ID: 26608487
[TBL] [Abstract][Full Text] [Related]
20. Estradiol, FSH and LH profiles in nine ethnic groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study.
Ausmanas MK; Tan DA; Jaisamrarn U; Tian XW; Holinka CF
Climacteric; 2007 Oct; 10(5):427-37. PubMed ID: 17852146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
